Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pierre Fabre reports antioxidants with neurologic activity

March 15, 1996

Antioxidants to treat Alzheimer's disease?

March 15, 1996

Cyclahexadiene derivatives reported by Bayer for AD

March 15, 1996

Myloral development update

March 15, 1996

Yamanouchi claims PCP antagonist for dementia

March 15, 1996

BB-3644 in development for multiple sclerosis

March 15, 1996

Lexipafant evaluated for MS treatment

March 15, 1996

Yissum claims novel anticonvulsants

March 15, 1996

Cephalon reports modafinil study results

March 15, 1996

Zeneca acquires antimigraine drug

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...